Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2023, Vol. 43 Issue (5): 85-93    DOI: 10.13523/j.cb.2211052
    
Research and Development Trend Analysis of Global Intestinal Microecology Industry Based on Patent Map
YU Yan1,WANG Chun-ming1,**(),XUE Liang2,TANG Zheng-wu1,ZHU Lin1,CHU Ying-min1,ZHANG Li-jia1
1 Guangdong Science & Technology Library(Information Research Institute of Guangdong Academy of Sciences), Guangzhou 510070, China
2 Institute of Microbiology,Guangdong Academy of Sciences, Guangzhou 510070, China
Download: HTML   PDF(2550KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

The human intestinal microbiome plays an important role in maintaining human health and the occurrence and development of diseases. The world is faced with some serious infectious diseases such as the novel coronavirus epidemic, and foodborne diseases, pathogenic drug-resistant “superbugs” and other problems are becoming more serious, threatening human health. Therefore, it is of great practical significance to use patent big data to carry out the analysis of the research and development (R&D) situation of the global intestinal microecology industry based on the patent map, make a preliminary judgment on the development direction of the intestinal microecology industry, and clarify the R&D hotspots. Based on the patent map, this paper focuses on analyzing the patent application trend, disclosure of applicants’ nations, inventor, technical composition, R&D hotspots, core patent technology path evolution trend and competitive influence of key institutions from 2011 to 2021 and from the dimensions of patent management map and patent technology map. The study found that the number of patent applications in the global intestinal microecology industry showed a gradual and rapid growth trend, reaching the second peak in 2020, and will continue to increase rapidly in the future. China is the country with the highest proportion of patent applications, acceptance and disclosure, and the top 10 first inventors (designers) in terms of application volume are mainly from China. The field of bacteroides|bacteria is a global R&D hotspot, the R&D hotspots of various countries have their own merits, and the overall complementary advantages have been formed.



Key wordsIntestinal microorganisms      Intestinal microecology      Patent map      Industrial pattern     
Received: 25 November 2022      Published: 01 June 2023
ZTFLH:  G250.252  
Cite this article:

YU Yan, WANG Chun-ming, XUE Liang, TANG Zheng-wu, ZHU Lin, CHU Ying-min, ZHANG Li-jia. Research and Development Trend Analysis of Global Intestinal Microecology Industry Based on Patent Map. China Biotechnology, 2023, 43(5): 85-93.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.2211052     OR     https://manu60.magtech.com.cn/biotech/Y2023/V43/I5/85

Fig.1 Overall development trend of patent applications for global intestinal microecology industry
Fig.2 The development trend of the top 10 countries in the global intestinal microecology industry patent applications from 2011 to 2021
Fig.3 2011-2021 Global intestinal microecology industry patent disclosure Top 10 countries’ spatial layout
第一发明(设计)人 专利数量/件 来自机构 所属国家
胡安然 75 劲膳美食品股份有限公司 中国
陈昕 60 劲膳美生物科技股份有限公司 中国
孙伟 31 营口富里实业有限公司 中国
魏来 23 珠海岐微生物科技有限公司 中国
Borody Thomas Julius 20 柳药医疗(Salix Pharmaceuticals) 美国
周东蕊 18 东南大学 中国
吴炳新 16 三株福尔制药有限公司 中国
董书阁 16 青岛嘉瑞生物技术有限公司 中国
Faure Magali 15 雀巢(Henri Nestle) 瑞士
舒国伟 14 陕西科技大学;陕西雅泰乳业有限公司 中国
Table 1 Top 10 first inventors (designers) in global patent applications for intestinal microecology industry in 2011-2021
序号 IPC号(小类) 分类号含义 专利申请量/件
1 A61K 医用、牙科用或梳妆用的配制品 2 775
2 A23L 食品、食料或非酒精饮料的制备或处理 2 359
3 A61P 化合物或药物制剂的特定治疗活性 2 090
4 A23K 专门适用于动物的喂养饲料;其生产方法 1 304
5 C12N 微生物或酶;其组合物;繁殖、保藏或维持微生物;变异或遗传工程等 1 185
6 C12R 与涉及微生物的C12C至C12Q小类相关的引得表 725
7 A23C 乳制品,如奶、黄油、干酪;奶或干酪的代用品;其制备 519
8 C12Q 包含酶、核酸或微生物的测定或检验方法 445
9 G01N 借助于测定材料的化学或物理性质来测试或分析材料 206
10 A23P 未被其他单一小类所完全包含的食料成型或加工 178
Table 2 IPC classification of top 10 global patent applications from 2011 to 2021
Fig.4 Global research and development hotspots of patented technology from 2011 to 2021
专利公开国别 专利数量/件 技术研发热点
中国 4 112 乳双歧杆菌|动物双歧杆菌|益生菌粉、肠道菌群|微生物群、微胶囊、饲料添加剂|微生态制剂|改善、新资源食品|碳水化合物|维生素、受试者|拟杆菌、药物|疾病|提取物、标志物|生物标志物|肠道内容物
韩国 379 植物乳杆菌|菌株|抗微生物活性、葡萄籽粉|肝脏脂肪变性、生物标志物|肠易激综合征|结肠直肠癌、提取物|饲料添加剂|功能性、内环境|个性化|活组织检查、甘露糖醛酸寡糖|还原端|不饱和、肠道微生物|机器学习|微生物数据、肠道|改善|肠内微生物
美国 301 肠道微生物|细菌|相对丰度、生物缀合物|肠道微生态、声动力治疗|光动力学|超声波照射、低聚半乳糖|双歧杆菌|短双歧杆菌、炎性疾病、溶菌酶活性|高精氨酸|多核苷酸、多磷酸激酶|多磷酸|保护剂、代谢性疾病、肠道疾病|木葡聚糖
日本 256 内环境|改善、益生元|人乳低聚糖、受试者|ASD|治疗、组对象|槐糖脂|动物饲料、菌群|改善剂、糖化率|声子、预处理剂|有机废物|有机废弃物、胆固醇血症|肠道炎症、微生物群|肠道细菌、益生菌制剂|肠道损伤|药物活性剂
加拿大 108 实施方案|肠功能障碍、哺乳动物|胆固醇血症|油性悬浮液、微生物群落|复合人|微通道、结肠直肠癌|部位特异性|艰难梭菌感染、豌豆蛋白|婴儿配方|原花青素、外阴阴道念珠菌病|念珠菌感染|戊糖乳杆菌、消化系统疾病|生产菌|过敏性肠综合征、抗微生物肽|共生细菌|生物活性大分子、高血氨症|肠道微生物|基因工程菌
墨西哥 54 胃肠道感染|功能性肠紊乱|胃肠感染、艰难梭菌感染|硝呋太尔|肠炎症疾病、水溶性碳水化合物|炎性疾病|百里香、口服途径给药|匹多莫德|直肠给药、溶菌酶活性|生物缀合物|动物饲料添加剂、益生素|低聚糖|蛋白质吸收、戊糖乳杆菌|细菌性阴道病|产气荚膜梭菌、微生物群|肠运动障碍|症状、生物活性大分子|大分子药物|生物活性剂
巴西 50 甜菊醇糖苷|一水柠檬酸|甜菊糖苷、NR4C|二苯并|梭菌、丙磺舒|酰胺化合物、曲美布汀|肠易激综合征|肠功能、食物不耐受|乳酸芽孢杆菌|链球菌属、慢性炎症性肠病|水溶性碳水化合物|干燥助剂、抗生素相关性腹泻|肠屏障|受试者、抗氧化剂|肠道微生物|维生素B5、骨骼健康|营养制剂|炎性肠病、组合物|细菌|细菌疾病
俄罗斯 45 肠道菌群|矿物材料、cRNA|微生物种群|宿主细胞、口服给药|消化道|艰难梭菌感染、肠易激综合征|帕金森病|肠细菌、组合物|舒适性|乳过氧化物酶、菌群失调|副干酪乳杆菌|反刍动物、防御素|哺乳动物|细胞因子风暴、抗腹泻剂|胃肠健康|生态失调
印度 40 肠道微生物菌群|药理学治疗|抗微生物剂、溶菌酶活性|同一性|多核苷酸、膜制剂|细菌、胃肠道菌群|阴道念珠菌病|蠕虫感染、甲烷排放|麦芽糖糊精|长双歧杆菌、益生元制剂|葫芦科植物|幼儿配方、功能性胃肠病症|功能性胃肠疾病|便秘症状、抗氧化剂|嗜水气单胞菌感染|益生菌培养物、口服途径给药|匹多莫德|肠溶包
澳大利亚 21 肠运动障碍|肠道微生物菌群|慢性应激、酪蛋白磷酸肽|复合微量元素|配方奶粉、功能性胃肠病症|肠黏膜屏障|功能性胃肠疾病、发酵饲料|断奶仔猪|发酵工艺优化、加氏乳杆菌|生牛奶|Lactobacillus、冻干物|再活化|黏附性、肠道菌群|黄腐酚|环境、布拉酵母|复合微生态制剂|副干酪乳杆菌、抗生素相关性腹泻|胃肠道|治疗剂、人乳低聚糖|岩藻糖基|调节肠道菌群
Table 3 2011-2021 Global Key National Patent Technology R&D Hotspots
Fig.5 Analysis on the evolution of core patent technology path of global intestinal microecology industry
Fig.6 Analysis on competitive influence of key R&D institutions in global intestinal microecology industry
[1]   宇岩. 基于文献计量的全球肠道微生态研发态势分析. 现代信息科技, 2020, 4(22): 1-5.
[1]   Yu Y. Analysis of global intestinal microecology research and development situation based on bibliometrics. Modern Information Technology, 2020, 4(22): 1-5.
[2]   陈烨, 刘乐. 肠道微生态与消化系统健康和疾病. 胃肠病学, 2020, 25(2): 65-69.
[2]   Chen Y, Liu L. Intestinal microecology in digestive system health and diseases. Chinese Journal of Gastroenterology, 2020, 25(2): 65-69.
[3]   Soderholm A T, Pedicord V A. Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity. Immunology, 2019, 158(4): 267-280.
doi: 10.1111/imm.13117 pmid: 31509239
[4]   Mi Y, Chin Y X, Cao W X, et al. Native κ-carrageenan induced-colitis is related to host intestinal microecology. International Journal of Biological Macromolecules, 2020, 147: 284-294.
doi: S0141-8130(19)39082-8 pmid: 31926226
[5]   He X, Yu B, He J, et al. Effects of xylanase on growth performance, nutrients digestibility and intestinal health in weaned piglets. Livestock Science, 2020, 233: 103940.
doi: 10.1016/j.livsci.2020.103940
[6]   Feng Q Q, Chen W D, Wang Y D. Gut microbiota: an integral moderator in health and disease. Frontiers in Microbiology, 2018, 9: 151.
doi: 10.3389/fmicb.2018.00151 pmid: 29515527
[7]   施慧琳, 苏燕, 徐萍, 等. 从专利角度分析全球益生菌研发态势. 科学观察, 2020, 15(1): 1-10.
[7]   Shi H L, Su Y, Xu P, et al. Global probiotics development trend analysis from the perspective of patent. Science Focus, 2020, 15(1): 1-10.
[8]   苗先锋. 肠道微生态产业发展现状分析. [2022-07-31]. https://www.cn-ferment.com/news/show-13472.html.
[8]   Miao X F. Analysis on the development status of intestinal microecology industry. [2022-07-31]. https://www.cn-ferment.com/news/show-13472.html.
[9]   丁陈君, 陈方, 张志强. 美国生物安全战略与计划体系及其启示与建议. 世界科技研究与发展, 2020, 42(3): 253-264.
[9]   Ding C J, Chen F, Zhang Z Q. The biosecurity strategy and planning framework of the United States and its enlightenments and suggestions. World Sci-Tech R & D, 2020, 42(3): 253-264.
[10]   杜青阳. 关于印发新型冠状病毒感染的肺炎诊疗方案(试行第五版)的通知. [2021-01-07]. http://www.gov.cn/zhengce/zhengceku/2020-02/05/content_5474791.htm.
[10]   Du Q Y. Notice on Printing and Distributing the Diagnosis and Treatment Plan for Pneumonia Infected by novel coronavirus (Trial Version 5). [2021-01-07]. http://www.gov.cn/zhengce/zhengceku/2020-02/05/content_5474791.htm.
[11]   宇岩, 祝林, 王春明, 等. 基于专利地图的东京湾区生物医药产业发展态势分析与启示. 世界科技研究与发展, 2022, 44(6): 813-824.
[11]   Yu Y, Zhu L, Wang C M, et al. Analysis and enlightenment of the development trend of biomedical industry in Tokyo Bay Area based on patent map. World Sci-Tech R & D, 2022, 44(6): 813-824.
[1] Hua-ling XIE,Dong-qiao LI,Pei-juan CHI,Yan-ping YANG. An Analysis on the Competition of Patents in Synthetic Biology[J]. China Biotechnology, 2019, 39(4): 114-123.
[2] XU Li, WANG Yue, YAO Chi-yuan, XU Ping. Trends and Development Bottleneck Analysis of Gene Editing Technology[J]. China Biotechnology, 2018, 38(12): 113-122.